Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308951917> ?p ?o ?g. }
- W4308951917 endingPage "348" @default.
- W4308951917 startingPage "337" @default.
- W4308951917 abstract "Abstract Higher vascular disease burden increases the likelihood of developing dementia, including Alzheimer’s disease. Better understanding the association between vascular risk factors and Alzheimer’s disease pathology at the predementia stage is critical for developing effective strategies to delay cognitive decline. In this work, we estimated the impact of six vascular risk factors on the presence and severity of in vivo measured brain amyloid-beta (Aβ) plaques in participants from the population-based Rotterdam Study. Vascular risk factors (hypertension, hypercholesterolaemia, diabetes, obesity, physical inactivity and smoking) were assessed 13 (2004–2008) and 7 years (2009–2014) prior to 18F-florbetaben PET (2018–2021) in 635 dementia-free participants. Vascular risk factors were associated with binary amyloid PET status or continuous PET readouts (standard uptake value ratios, SUVrs) using logistic and linear regression models, respectively, adjusted for age, sex, education, APOE4 risk allele count and time between vascular risk and PET assessment. Participants’ mean age at time of amyloid PET was 69 years (range: 60–90), 325 (51.2%) were women and 190 (29.9%) carried at least one APOE4 risk allele. The adjusted prevalence estimates of an amyloid-positive PET status markedly increased with age [12.8% (95% CI 11.6; 14) in 60–69 years versus 35% (36; 40.8) in 80–89 years age groups] and APOE4 allele count [9.7% (8.8; 10.6) in non-carriers versus 38.4% (36; 40.8) to 60.4% (54; 66.8) in carriers of one or two risk allele(s)]. Diabetes 7 years prior to PET assessment was associated with a higher risk of a positive amyloid status [odds ratio (95% CI) = 3.68 (1.76; 7.61), P < 0.001] and higher standard uptake value ratios, indicating more severe Aβ pathology [standardized beta = 0.40 (0.17; 0.64), P = 0.001]. Hypertension was associated with higher SUVr values in APOE4 carriers (mean SUVr difference of 0.09), but not in non-carriers (mean SUVr difference 0.02; P = 0.005). In contrast, hypercholesterolaemia was related to lower SUVr values in APOE4 carriers (mean SUVr difference −0.06), but not in non-carriers (mean SUVr difference 0.02). Obesity, physical inactivity and smoking were not related to amyloid PET measures. The current findings suggest a contribution of diabetes, hypertension and hypercholesterolaemia to the pathophysiology of Alzheimer’s disease in a general population of older non-demented adults. As these conditions respond well to lifestyle modification and drug treatment, further research should focus on the preventative effect of early risk management on the development of Alzheimer’s disease neuropathology." @default.
- W4308951917 created "2022-11-20" @default.
- W4308951917 creator A5011696527 @default.
- W4308951917 creator A5013665840 @default.
- W4308951917 creator A5015741776 @default.
- W4308951917 creator A5049890386 @default.
- W4308951917 creator A5051620196 @default.
- W4308951917 creator A5054662814 @default.
- W4308951917 creator A5074357562 @default.
- W4308951917 creator A5074391532 @default.
- W4308951917 date "2022-11-12" @default.
- W4308951917 modified "2023-10-17" @default.
- W4308951917 title "Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study" @default.
- W4308951917 cites W1645350431 @default.
- W4308951917 cites W1982959887 @default.
- W4308951917 cites W1984964878 @default.
- W4308951917 cites W1993571512 @default.
- W4308951917 cites W1994181115 @default.
- W4308951917 cites W1995118675 @default.
- W4308951917 cites W1999631936 @default.
- W4308951917 cites W2003091888 @default.
- W4308951917 cites W2022655041 @default.
- W4308951917 cites W2027987672 @default.
- W4308951917 cites W2028713570 @default.
- W4308951917 cites W2047972989 @default.
- W4308951917 cites W2055568131 @default.
- W4308951917 cites W2076517751 @default.
- W4308951917 cites W2101135654 @default.
- W4308951917 cites W2102528806 @default.
- W4308951917 cites W2109958697 @default.
- W4308951917 cites W2112499304 @default.
- W4308951917 cites W2117842413 @default.
- W4308951917 cites W2119989228 @default.
- W4308951917 cites W2122130235 @default.
- W4308951917 cites W2134801005 @default.
- W4308951917 cites W2145812954 @default.
- W4308951917 cites W2151465594 @default.
- W4308951917 cites W2158407564 @default.
- W4308951917 cites W2160143874 @default.
- W4308951917 cites W2162069510 @default.
- W4308951917 cites W2168357345 @default.
- W4308951917 cites W2169508236 @default.
- W4308951917 cites W2171129594 @default.
- W4308951917 cites W2275822978 @default.
- W4308951917 cites W2346799997 @default.
- W4308951917 cites W2414917913 @default.
- W4308951917 cites W2570267351 @default.
- W4308951917 cites W2605454964 @default.
- W4308951917 cites W2606855624 @default.
- W4308951917 cites W2607031541 @default.
- W4308951917 cites W2613800048 @default.
- W4308951917 cites W2783990575 @default.
- W4308951917 cites W2786962139 @default.
- W4308951917 cites W2792178736 @default.
- W4308951917 cites W2793877525 @default.
- W4308951917 cites W2803367816 @default.
- W4308951917 cites W2900711667 @default.
- W4308951917 cites W2903206466 @default.
- W4308951917 cites W2905614745 @default.
- W4308951917 cites W2944393185 @default.
- W4308951917 cites W2964401163 @default.
- W4308951917 cites W2965401191 @default.
- W4308951917 cites W2969795325 @default.
- W4308951917 cites W2984495183 @default.
- W4308951917 cites W2992371953 @default.
- W4308951917 cites W3004417746 @default.
- W4308951917 cites W3017051753 @default.
- W4308951917 cites W3022537071 @default.
- W4308951917 cites W3023972366 @default.
- W4308951917 cites W3041479049 @default.
- W4308951917 cites W3046275966 @default.
- W4308951917 cites W3103328760 @default.
- W4308951917 cites W3111203418 @default.
- W4308951917 cites W3129560832 @default.
- W4308951917 cites W3143545452 @default.
- W4308951917 cites W3159217995 @default.
- W4308951917 cites W3160870314 @default.
- W4308951917 cites W3166921190 @default.
- W4308951917 cites W3186160794 @default.
- W4308951917 cites W3197429953 @default.
- W4308951917 cites W3210179375 @default.
- W4308951917 cites W3217561425 @default.
- W4308951917 cites W4238251256 @default.
- W4308951917 cites W4246169631 @default.
- W4308951917 doi "https://doi.org/10.1093/brain/awac354" @default.
- W4308951917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36374264" @default.
- W4308951917 hasPublicationYear "2022" @default.
- W4308951917 type Work @default.
- W4308951917 citedByCount "10" @default.
- W4308951917 countsByYear W43089519172023 @default.
- W4308951917 crossrefType "journal-article" @default.
- W4308951917 hasAuthorship W4308951917A5011696527 @default.
- W4308951917 hasAuthorship W4308951917A5013665840 @default.
- W4308951917 hasAuthorship W4308951917A5015741776 @default.
- W4308951917 hasAuthorship W4308951917A5049890386 @default.
- W4308951917 hasAuthorship W4308951917A5051620196 @default.
- W4308951917 hasAuthorship W4308951917A5054662814 @default.
- W4308951917 hasAuthorship W4308951917A5074357562 @default.